Search Results - "DRUG side effects"

Beyond lab animals.

Authors: Reardon, Sara¹

Source: Science. 8/14/2025, Vol. 389 Issue 6761, p676-679. 4p.

Prevalence and Characteristics of Deoxycholate and Liposomal Amphotericin B Adverse Reactions in a Third‐Level Care Hospital: A Retrospective Observational Study.

Authors: Vargas, Thalia Berenice Jacobo Portugal, Miriam del Carmen Carrasco Saldaña, Renata Báez et al.

Source: Journal of Clinical Pharmacy & Therapeutics. 6/21/2026, Vol. 2026, p1-7. 7p.

Systemic Cancer Therapy‐Related Adverse Drug Reactions and Associated Clinical Outcomes Among Lymphoma Patients at Kenyatta National Hospital.

Authors: Mochere, Ivy Kerubo Degu, Amsalu Xu, Yue

Source: Journal of Clinical Pharmacy & Therapeutics. 6/18/2026, Vol. 2026, p1-9. 9p.

Causality assessment of adverse events by healthcare professionals in an academic hospital setting: a descriptive retrospective study.

Authors: Corbin, Sonia Lavallée, Maude Pradhan, Pallavi et al.

Source: Canadian Journal of Physiology & Pharmacology. 2025, Vol. 103 Issue 5, p172-181. 10p.

The Latest Ozempic Side Effect? It May Make You Less Violent.

Authors: Murray, Conor (AUTHOR)

Source: Forbes.com. 6/17/2026, pN.PAG-N.PAG. 1p.

Clozapine-Associated Generalized Seizure at Therapeutic Dose Without Prior Epilepsy: A Case Report.

Authors: Aweke, Kebron W. Kebede, Yonathan Belay Bayu, Elias Getahun et al.

Source: Clinical Medicine Insights: Case Reports. 7/8/2026, Vol. 19, p1-5. 5p.

Paralytic Ileus in a 45-Year-Old Female with Schizophrenia on Clozapine Therapy.

Authors: Patil, Shivraj Prashant Harale, Manasi Vinayak Janani, R. et al.

Source: Annals of African Medicine. Jul/Aug2026, Vol. 25 Issue 4, p935-939. 5p.

Severe Euglycemic Ketoacidosis Following Unsupervised Tirzepatide Dose Escalation in a Non-Obese, Non-Diabetic Woman.

Authors: Abdelshafey, Eslam Sewify, Khaled Almutairi, Atheer et al.

Source: American Journal of Case Reports. 7/1/2026, Vol. 27, p1-5. 5p.

Gastrointestinal adverse events related to monoclonal antibodies: A comprehensive evaluation of data from the FDA Adverse Event Reporting System database.

Authors: Kumar, Nitin Kalaiselvan, Vivekanandan Arora, Mandeep Kumar

Source: Indian Journal of Pharmacology. Jul/Aug2026, Vol. 58 Issue 4, p375-386. 12p.

Systemic pathways linking subcutaneous therapies to gastrointestinal adverse effects: A Narrative review of mechanisms and mitigation strategies.

Authors: Singh, Alok Yadav, Dinesh Singh, Madhusudan Prasad

Source: Indian Journal of Pharmacology. Jul/Aug2026, Vol. 58 Issue 4, p307-318. 12p.

A Multicenter Analysis of Patients with Bullous Pemphigoid: Clinical Characteristics and Insights into Drug-Associated Disease.

Authors: Małolepsza, Aleksandra Kośny, Aleksandra Juczyńska, Katarzyna et al.

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 12, p5587. 15p.

Vigabatrin-Associated Brain Abnormalities on MRI in a Patient with PCDH19-Clustering Epilepsy.

Authors: Apanasenko, Olena Głodek-Brzozowska, Ewelina Guz, Paweł et al.

Source: Journal of Clinical Medicine. Jun2026, Vol. 15 Issue 12, p4619. 16p.

De novo clinical endocrine immune-related adverse events during immune checkpoint inhibitor therapy in adults with cancer (2000–2025) – a scoping review.

Authors: Pillay, S¹ (AUTHOR) drspillay@iafrica.com

Source: Journal of Endocrinology, Metabolism & Diabetes of South Africa. Jun2026, p1-6. 6p. 1 Illustration.

Human-in-the-Loop Soft Prompt Tuning for Adverse Drug Event Extraction from Clinical Notes.

Authors: Modi, Salisu Kasmiran, Khairul Azhar Sharef, Nurfadhlina Mohd et al.

Source: Pertanika Journal of Science & Technology; Jun2026, Vol. 34 Issue 3, p1769-1800, 32p

药物源性男性不育症不良事件信号挖掘与风险 特征分析:一项真实世界研究.

Alternate Title: Signal Mining and Risk Characterization of Drug-Induced Male Infertility Adverse Events: A Real-World Study.

Authors: 龚卓之 郭 军 冯秋涧 et al.

Source: Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi. 2026, Vol. 26 Issue 6, p754-759. 6p.

托法替布不良事件信号挖掘与分析:基于 FAERS 的 真实世界药物警戒研究.

Alternate Title: Mining and Analysis of Tofacitinib-Associated Adverse Drug Event Signals: A Real-World Pharmacovigilance Study Based on FAERS Database.

Authors: 周志伟 张 波 端木雯婧 et al.

Source: Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi. 2026, Vol. 26 Issue 6, p760-764. 5p.

Proactive, Multidisciplinary AE Management Enables Safer, Sustained ADC Use in Breast and Lung Cancers.

Authors: WAHNER, ASHLING

Source: OncologyLive. Jun2026, Vol. 27 Issue 6, p18-21. 4p.

Adverse Effects of Biologic Therapy: A Retrospective Cohort Study.

Authors: Shkodrani, Entela Ruci, Dorina Xhaja, Alert et al.

Source: Pharmacoepidemiology (2813-0618). Jun2026, Vol. 5 Issue 2, p15. 7p.

Prospective Multicenter Observational Study of Anlotinib in Advanced Non‐Small Cell Lung Cancer: Real‐World Evidence From China.

Authors: Wang, Jinlin Dong, Youhong Cao, Fengjun et al.

Source: Thoracic Cancer. Jun2026, Vol. 17 Issue 11, p1-12. 12p.

Drug-induced Acneiform Breakout in a Postpartum Psychosis Patient: A Case Report with Literature Review.

Authors: M, Deepalakshmi M, Sudharsan S, Rajalakshmi et al.

Source: Journal of Pharmacology & Pharmacotherapeutics. Jun2026, Vol. 17 Issue 2, p308-314. 7p.